Skip to main content
. 2019 Sep 2;9:12659. doi: 10.1038/s41598-019-49159-0

Figure 1.

Figure 1

Dry eye changes and meibomian gland dysfunction (MGD) parameters during the treatment period in patients with pre-existing dry eye disease (DED). Mean changes in tear breakup time (TBUT) (a), Schirmer test scores (b), corneal staining scores (c), and Ocular Surface Disease Index (OSDI) (d) were used to assess dry eye parameters. Mean changes in lipid layer thickness (LLT) (e), MGD stage (f), lid margin abnormalities (g), meibomian gland expressibility (h), and meibum quality (i) were used as MGD parameters. Data are presented as mean values ± standard error of the mean (SEM). P-values are presented next to all graphs for each study period, indicating the results of statistical analyses among the 3 groups for that period using analysis of variance; P-value indicates the overall difference analysis throughout the study period by generalized estimating equation; indicates a statistically significant difference between groups 1 and 2 per post hoc analysis; indicates a statistically significant difference between groups 1 and 3 per post hoc analysis; §indicates a statistically significant difference between groups 2 and 3 per post hoc analysis.